These codes are used to report injectable drugs that ordinarily cannot be self-administered; chemotherapy, immunosuppressive drugs and inhalation solutions as well as some orally administered drugs.

View All HCPCS Sections

• J3411

  Injection, thiamine hcl, 100 mg

• J3415

  Injection, pyridoxine hcl, 100 mg

• J3420

  Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg

• J3424

  Injection, hydroxocobalamin, intravenous, 25 mg

• J3425

  Injection, hydroxocobalamin, intramuscular, 10 mcg

• J3430

  Injection, phytonadione (vitamin k), per 1 mg

• J3465

  Injection, voriconazole, 10 mg

• J3470

  Injection, hyaluronidase, up to 150 units

• J3471

  Injection, hyaluronidase, ovine, preservative free, per 1 usp unit (up to 999 usp units)

• J3472

  Injection, hyaluronidase, ovine, preservative free, per 1000 usp units

• J3473

  Injection, hyaluronidase, recombinant, 1 usp unit

• J3475

  Injection, magnesium sulfate, per 500 mg

• J3480

  Injection, potassium chloride, per 2 meq

• J3485

  Injection, zidovudine, 10 mg

• J3486

  Injection, ziprasidone mesylate, 10 mg

• J3489

  Injection, zoledronic acid, 1 mg

• J3490

  Unclassified drugs

• J3520

  Edetate disodium, per 150 mg

• J3530

  Nasal vaccine inhalation

• J3535

  Drug administered through a metered dose inhaler

• J3570

  Laetrile, amygdalin, vitamin b17

• J3590

  Unclassified biologics

• J3591

  Unclassified drug or biological used for esrd on dialysis

• J7030

  Infusion, normal saline solution , 1000 cc

• J7040

  Infusion, normal saline solution, sterile (500 ml = 1 unit)

• J7042

  5% dextrose/normal saline (500 ml = 1 unit)

• J7050

  Infusion, normal saline solution, 250 cc

• J7060

  5% dextrose/water (500 ml = 1 unit)

• J7070

  Infusion, d5w, 1000 cc

• J7100

  Infusion, dextran 40, 500 ml

• J7110

  Infusion, dextran 75, 500 ml

• J7120

  Ringers lactate infusion, up to 1000 cc

• J7121

  5% dextrose in lactated ringers infusion, up to 1000 cc

• J7131

  Hypertonic saline solution, 1 ml

• J7165

  Injection, prothrombin complex concentrate, human-lans, per i.u. of factor ix activity

• J7168

  Prothrombin complex concentrate (human), kcentra, per i.u. of factor ix activity

• J7169

  Injection, coagulation factor xa (recombinant), inactivated-zhzo (andexxa), 10 mg

• J7170

  Injection, emicizumab-kxwh, 0.5 mg

• J7171

  Injection, adamts13, recombinant-krhn, 10 iu

• J7172

  Injection, marstacimab-hncq, 0.5 mg

• J7173

  Injection, concizumab-mtci, 0.5 mg

• J7174

  Injection, fitusiran, 0.04 mg

• J7175

  Injection, factor x, (human), 1 i.u.

• J7177

  Injection, human fibrinogen concentrate (fibryga), 1 mg

• J7178

  Injection, human fibrinogen concentrate, not otherwise specified, 1 mg

• J7179

  Injection, von willebrand factor (recombinant), (vonvendi), 1 i.u. vwf:rco

• J7180

  Injection, factor xiii (antihemophilic factor, human), 1 i.u.

• J7181

  Injection, factor xiii a-subunit, (recombinant), per iu

• J7182

  Injection, factor viii, (antihemophilic factor, recombinant), (novoeight), per iu

• J7183

  Injection, von willebrand factor complex (human), wilate, 1 i.u. vwf:rco

---

HCPCS Level II codes and descriptors are approved and maintained jointly by the alpha-numeric editorial panel (consisting of CMS, the Health Insurance Association of America, and the Blue Cross and Blue Shield Association). — Updated 6/4/2026

CPT^® is a registered trademark of the American Medical Association (AMA). All rights reserved.